Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (8)

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

JNCI Cancer Spectrum
2025-03-03 | Journal article
DOI: 10.1093/jncics/pkaf020
Contributors: Christian Corsini; Pietro Scilipoti; Andri Wilberg Orrason; Rolf Gedeborg; Marcus Westerberg; Pär Stattin
Source: check_circle
Crossref

Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

BJU International
2025-02-18 | Journal article
DOI: 10.1111/bju.16675
Contributors: Pietro Scilipoti; Mattia Longoni; Mario de Angelis; Paolo Zaurito; Aleksander Ślusarczyk; Francesco Soria; Benjamin Pradere; Wojciech Krajewski; David D'Andrea; Andrea Mari et al.
Source: check_circle
Crossref

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

JNCI: Journal of the National Cancer Institute
2025-01-17 | Journal article
DOI: 10.1093/jnci/djaf012
Contributors: Pietro Scilipoti; Hans Garmo; Rolf Gedeborg; David Robinson; Pär Stattin; Marcus Westerberg
Source: check_circle
Crossref

Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: EuroGemDoce group results

BJU International
2025-01-11 | Journal article
DOI: 10.1111/bju.16645
Contributors: Pietro Scilipoti; Mattia Longoni; Mario de Angelis; Paolo Zaurito; Albane Massiet; Daniele Dutto; Francesco Soria; Mario Álvarez‐Maestro; Alfredo Aguilera Bazán; Benjamin Pradere et al.
Source: check_circle
Crossref

Mitomycin C vs. Bacillus Calmette–Guerin for treatment of intermediate-risk nonmuscle invasive bladder cancer patients—A comparative analysis from a single center

Urologic Oncology: Seminars and Original Investigations
2024-12 | Journal article
DOI: 10.1016/j.urolonc.2024.06.026
Contributors: Pietro Scilipoti; Mattia Longoni; Mario de Angelis; Chiara Re; Alessandro Bertini; Donato Cannoletta; Giusy Burgio; Roberta Lucianò; Giuseppe Rosiello; Renzo Colombo et al.
Source: check_circle
Crossref

The Role of Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

European Urology Oncology
2024-12 | Journal article
DOI: 10.1016/j.euo.2024.06.005
Contributors: Pietro Scilipoti; Aleksander Ślusarczyk; Mario de Angelis; Francesco Soria; Benjamin Pradere; Wojciech Krajewski; David D’Andrea; Andrea Mari; Francesco Del Giudice; Renate Pichler et al.
Source: check_circle
Crossref

Long‐term functional outcomes after robot‐assisted radical cystectomy with intracorporeal ileal orthotopic neobladder

BJU International
2024-07 | Journal article
DOI: 10.1111/bju.16337
Contributors: Francesco Pellegrino; Pietro Scilipoti; Giuseppe Rosiello; Mattia Longoni; Riccardo Leni; Giuseppe Basile; Leonardo Quarta; Paolo Zaurito; Chiara Re; Mario de Angelis et al.
Source: check_circle
Crossref

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat­ectomy. A nationwide population-based study

Scandinavian Journal of Urology
2024-05-13 | Journal article
DOI: 10.2340/sju.v59.40001
Contributors: Pietro Scilipoti; Fredrik Liedberg; Hans Garmo; Andri Wilberg Orrason; Pär Stattin; Marcus Westerberg
Source: check_circle
Crossref
How many people are using ORCID?